Cargando…
Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes
Light chain (AL) amyloidosis is the most common form of systemic amyloid disease, and cardiomyopathy is a dire consequence, resulting in an extremely poor prognosis. AL is characterized by the production of monoclonal free light chains that deposit as amyloid fibrils principally in the heart, liver,...
Autores principales: | McWilliams-Koeppen, Helen P., Foster, James S., Hackenbrack, Nicole, Ramirez-Alvarado, Marina, Donohoe, Dallas, Williams, Angela, Macy, Sallie, Wooliver, Craig, Wortham, Dale, Morrell-Falvey, Jennifer, Foster, Carmen M., Kennel, Stephen J., Wall, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579077/ https://www.ncbi.nlm.nih.gov/pubmed/26393799 http://dx.doi.org/10.1371/journal.pone.0137716 |
Ejemplares similares
-
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2015) -
A Peptide-Fc Opsonin with Pan-Amyloid Reactivity
por: Foster, James S., et al.
Publicado: (2017) -
AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils
por: Wall, Jonathan S., et al.
Publicado: (2012) -
Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion
por: Foster, James S., et al.
Publicado: (2023) -
Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide (124)I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging
por: Martin, Emily B., et al.
Publicado: (2023)